Clostridium difficile-associated diarrhea in 200 Canadian children

Canadian Journal of Gastroenterology

Volumn 19, Issue 8, 2005, Pages 497-501

  Morinville, Véronique ^a   McDonald, Jane ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Clostridium difficile; Diarrhea; Morbidity; Pediatrics

Indexed keywords

ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN B; COLESTYRAMINE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; RIFAMPICIN; VANCOMYCIN;

BACTERIAL INFECTION; CANADA; CHILD; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; FECES ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24644517007     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/326296     Document Type: Review

References (35)

1. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405-10.
2. Buchner AM, Sonnenberg A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am J Gastroenterol 2001;96:766-72.
3. Djuretic F, Wall PG, Brazier JS. Clostridium difficile: An update on its epidemiology and role in hospital outbreaks in England and Wales. J Hosp Infect 1999;41:213-8.
4. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol Clin North Am 2001;30:753-77.
5. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: An increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096-100.
6. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:739-50.
7. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243-5.
8. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea in hospital in-patients prescribed proton pump inhibitors: Cohort and case-control studies. CMAJ 2004;171:33-8.
9. Elmer GW, McFarland LV. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001;30:837-54.
10. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991;118:633-7.
11. Liacouras CA, Piccoli DA. Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis. J Clin Gastroenterol 1996;22:186-9.
12. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271:1913-8.
13. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: Treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
14. Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366-70.
15. Schwan A, Sjolins, Trottestam V, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal feces. Scand J Infect Dis 1984;16:211-5.
16. Burgner D, Siarakas S, Eagles G, McCarthy A, Bradbury R, Stevens M. A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients. Pediatr Infect Dis J 1997;16:1131-4.
17. Canadian Paediatric Society Infectious Diseases and Immunization Committee. Clostridium difficile - Pathogen or pest? Paediatr Child Health 2000;5:349-52.
18. Cerquetti M, Luzzi I, Caprioli A, Sebastianelli A, Mastrantonio P. Role of Clostridium difficile in childhood diarrhea. Pediatr Infect Dis J 1995;14:598-603.
19. McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: A phantom menace or clinical reality? J Pediatr Gastroenterol Nutr 2000;31:220-31.
20. Thompson CM, Gilligan PH, Fisher MC, Long SS. Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child 1983;137:271-4.
21. West M, Pirenne J, Chavers B, et al. Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant 1999;13:318-23.
22. Wolfhagen MJ, Meijer K, Fluit AC, et al. Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromized children. Gut 1994;35:1608-12.
23. Enad D, Meislich D, Brodsky NL, Hurt H. Is Clostridium difficile a pathogen in the newborn intensive care unit? A prospective evaluation. J Perinatol 1997;17:355-9.
24. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-33.
25. Tullus K, Aronsson B, Marcus S, Mollby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis 1989;8:390-3.
26. Boenning DA, Fleisher GR, Campos JM, Hulkower CW, Quinlan RW. Clostridium difficile in a pediatric outpatient population. Pediatr Infect Dis 1982;1:336-8.
27. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: A review. Clin Infect Dis 1993;17:109-13.
28. Blot E, Escande MC, Besson D, et al. Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: Risk factors and microbiological characteristics. J Hosp Infect 2003;53:187-92.
29. Husain A, Aptaker L, Spriggs DR, Barakat RR. Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol Oncol 1998;71:104-7.
30. Jarvis B, Shevchuk YM. Recurrent Clostridium difficile diarrhea associated with mitoxantrone and etoposide: A case report and review. Pharmacotherapy 1997;17:606-11.
31. Tomblyn M, Gordon L, Singhai S, et al. Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: Implications for symptomatic management of diarrhea. Bone Marrow Transplant 2002;30:517-9.
32. Qualman SJ, Petric M, Karmali MA, Smith CR, Hamilton SR. Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol 1990;94:410-6.
33. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
34. Kyne L, Warny M, Qamar A, Kelly CF. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390-7.
35. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996;91:460-4.